Palette Life Sciences

Palette Life Sciences is a medical device company specializing in Non-Animal Stabilized Hyaluronic Acid (NASHA) technologies for interventional urology, urogynecology, colorectal conditions, radiotherapy, and interventional oncology. The company develops innovative tissue bulking and spacer agents designed to address specialized clinical needs often underserved by larger medical device manufacturers. Acquired by Teleflex Incorporated in October 2023, Palette Life Sciences' product portfolio includes spacers for prostate cancer radiotherapy, tissue bulking agents for vesicoureteral reflux management, and solutions for fecal incontinence. The company's NASHA-based technology platform enables minimally invasive interventions across urology, gynecology, and colorectal specialties.